國立虎尾科技大學 |

Myotonic Dystrophy = Disease Mechanism, Current Management and Therapeutic Development /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Myotonic Dystrophy/ edited by Masanori P. Takahashi, Tsuyoshi Matsumura.
Reminder of title:	Disease Mechanism, Current Management and Therapeutic Development /
other author:	Takahashi, Masanori P.
Description:	VIII, 214 p. 58 illus., 42 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Neurology . -
Online resource:	https://doi.org/10.1007/978-981-13-0508-5
ISBN:	9789811305085

Myotonic Dystrophy = Disease Mechanism, Current Management and Therapeutic Development /
Myotonic DystrophyDisease Mechanism, Current Management and Therapeutic Development /[electronic resource] :edited by Masanori P. Takahashi, Tsuyoshi Matsumura. - 1st ed. 2018. - VIII, 214 p. 58 illus., 42 illus. in color.online resource.

Genetics of myotonic dystrophy (including cDM and DM2) -- Basic Molecular pathomechanism -- Clinical features in skeletal muscle and their underlying molecular mechanism -- Clinical features in heart and their underlying molecular mechanism -- Clinical features of central nervous system -- Pathological changes in DM brain -- Molecular defect in DM central nervous system -- Respiratory feature in DM -- Glucose intolerance in DM -- Lipid metabolism in DM -- Dysphagia in DM -- DM patient-derived iPS cells -- Therapeutic development in DM.

This book provides an essential overview combining both clinical and fundamental research advances in myotonic dystrophy. The pathomechanism of myotonic dystrophy has long been unclear, but in the past decade, our understanding has shifted to a novel disease mechanism concept: “RNA disease”. Parallel to these advances in elucidating the pathophysiology, translational research is also progressing rapidly. The current challenge lies in assessing the effectiveness of treatment, and as such, there is a growing interest in observational studies of the disease’s various clinical symptoms. The book introduces readers to the molecular mechanisms within each organ and the resultant clinical features, which are presented together. In particular, it focuses on the central nervous system, since the pathology of the brain (central nervous system manifestation) has rarely been addressed systematically and will pose a persistent challenge, even if therapies have greatly advanced in the future. In addition, the book addresses the latest developments, such as research using patient-derived iPS cells and therapeutic research. Myotonic Dystrophy provides essential information for neurologists and researchers with an interest in muscle disease, including muscular dystrophy. Furthermore, since the disease involves various complications of the brain, heart, metabolism, etc., the book will be of great value to clinicians and researchers in the cardiovascular sciences, endocrinology, diabetes, dementia, and neuropsychology, as well as genetic specialists.

ISBN: 9789811305085

Standard No.: 10.1007/978-981-13-0508-5doiSubjects--Topical Terms:

1253459
Neurology .

LC Class. No.: RC346-429.2

Dewey Class. No.: 616.8

Myotonic Dystrophy = Disease Mechanism, Current Management and Therapeutic Development /
LDR:03489nam a22003975i 4500 001 987210
003 DE-He213
005 20200630121400.0
007 cr nn 008mamaa
008 201225s2018 si | s |||| 0|eng d
020 $a 9789811305085 $9 978-981-13-0508-5
024 7 $a 10.1007/978-981-13-0508-5 $2 doi
035 $a 978-981-13-0508-5
050 4 $a RC346-429.2
072 7 $a MJN $2 bicssc
072 7 $a MED056000 $2 bisacsh
072 7 $a MKJ $2 thema
082 0 4 $a 616.8 $2 23
245 1 0 $a Myotonic Dystrophy $h [electronic resource] : $b Disease Mechanism, Current Management and Therapeutic Development / $c edited by Masanori P. Takahashi, Tsuyoshi Matsumura.
250 $a 1st ed. 2018.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2018.
300 $a VIII, 214 p. 58 illus., 42 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Genetics of myotonic dystrophy (including cDM and DM2) -- Basic Molecular pathomechanism -- Clinical features in skeletal muscle and their underlying molecular mechanism -- Clinical features in heart and their underlying molecular mechanism -- Clinical features of central nervous system -- Pathological changes in DM brain -- Molecular defect in DM central nervous system -- Respiratory feature in DM -- Glucose intolerance in DM -- Lipid metabolism in DM -- Dysphagia in DM -- DM patient-derived iPS cells -- Therapeutic development in DM.
520 $a This book provides an essential overview combining both clinical and fundamental research advances in myotonic dystrophy. The pathomechanism of myotonic dystrophy has long been unclear, but in the past decade, our understanding has shifted to a novel disease mechanism concept: “RNA disease”. Parallel to these advances in elucidating the pathophysiology, translational research is also progressing rapidly. The current challenge lies in assessing the effectiveness of treatment, and as such, there is a growing interest in observational studies of the disease’s various clinical symptoms. The book introduces readers to the molecular mechanisms within each organ and the resultant clinical features, which are presented together. In particular, it focuses on the central nervous system, since the pathology of the brain (central nervous system manifestation) has rarely been addressed systematically and will pose a persistent challenge, even if therapies have greatly advanced in the future. In addition, the book addresses the latest developments, such as research using patient-derived iPS cells and therapeutic research. Myotonic Dystrophy provides essential information for neurologists and researchers with an interest in muscle disease, including muscular dystrophy. Furthermore, since the disease involves various complications of the brain, heart, metabolism, etc., the book will be of great value to clinicians and researchers in the cardiovascular sciences, endocrinology, diabetes, dementia, and neuropsychology, as well as genetic specialists.
650 0 $a Neurology . $3 1253459
650 0 $a Cardiology. $3 593957
650 0 $a Metabolic diseases. $3 1253620
650 0 $a Human genetics. $3 596505
650 1 4 $a Neurology. $3 593894
650 2 4 $a Metabolic Diseases. $3 593967
650 2 4 $a Human Genetics. $3 593893
700 1 $a Takahashi, Masanori P. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1210662
700 1 $a Matsumura, Tsuyoshi. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1210663
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811305078
776 0 8 $i Printed edition: $z 9789811305092
776 0 8 $i Printed edition: $z 9789811344367
856 4 0 $u https://doi.org/10.1007/978-981-13-0508-5
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)